Akèy › Leukemi › Pennsylvania › Philadelphia
Etid klinik pou Leukemi nan Philadelphia, PA
12 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia, Philadelphia
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Ap rekriteFaz 1
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Ap rekriteFaz 2
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
Ap rekriteEtid obsèvasyon
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Ap rekriteEtid obsèvasyon
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Ap rekriteFaz 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Ap rekriteFaz 1 bonè
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Philadelphia
Etid Leukemi nan lòt vil
- Houston, TX28 etid
- Boston, MA25 etid
- New York City, NY19 etid
- Los Angeles, CA16 etid
- Chicago, IL16 etid
- Durham, NC13 etid
- Baldwin Park, CA12 etid
- Columbus, OH12 etid
- Nashville, TN12 etid
- Milwaukee, WI11 etid
- Atlanta, GA11 etid
- Seattle, WA11 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè pwostat44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.